Susquehanna International Group’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-268,393
| Closed | -$19.4M | – | 13967 |
|
|
2025
Q4 | $19.4M | Buy |
268,393
+223,034
| +492% | +$14.4M | ﹤0.01% | 2250 |
|
|
2025
Q3 | $1.98M | Sell |
45,359
-130,584
| -74% | -$5.28M | ﹤0.01% | 5821 |
|
|
2025
Q2 | $5M | Sell |
175,943
-17,120
| -9% | -$510K | ﹤0.01% | 3967 |
|
|
2025
Q1 | $5.7M | Buy |
193,063
+118,171
| +158% | +$3.68M | ﹤0.01% | 3409 |
|
|
2024
Q4 | $2.18M | Buy |
74,892
+41,679
| +125% | +$1.74M | ﹤0.01% | 5115 |
|
|
2024
Q3 | $1.53M | Sell |
33,213
-525
| -2% | -$22.8K | ﹤0.01% | 5870 |
|
|
2024
Q2 | $1.38M | Buy |
33,738
+20,017
| +146% | +$574K | ﹤0.01% | 5848 |
|
|
2024
Q1 | $350K | Sell |
13,721
-50,834
| -79% | -$797K | ﹤0.01% | 9346 |
|
|
2023
Q4 | $584K | Buy |
64,555
+7,675
| +13% | +$51.3K | ﹤0.01% | 8280 |
|
|
2023
Q3 | $363K | Sell |
56,880
-11,070
| -16% | -$95.4K | ﹤0.01% | 8951 |
|
|
2023
Q2 | $754K | Sell |
67,950
-44,362
| -39% | -$556K | ﹤0.01% | 7344 |
|
|
2023
Q1 | $1.72M | Buy |
112,312
+93,268
| +490% | +$2.05M | ﹤0.01% | 5468 |
|
|
2022
Q4 | $423K | Sell |
19,044
-41,500
| -69% | -$619K | ﹤0.01% | 8287 |
|
|
2022
Q3 | $989K | Buy |
60,544
+43,604
| +257% | +$834K | ﹤0.01% | 6659 |
|
|
2022
Q2 | $246K | Sell |
16,940
-3,406
| -17% | -$50.7K | ﹤0.01% | 10111 |
|
|
2022
Q1 | $376K | Sell |
20,346
-16,177
| -44% | -$275K | ﹤0.01% | 9704 |
|
|
2021
Q4 | $868K | Buy |
36,523
+9,609
| +36% | +$229K | ﹤0.01% | 7663 |
|
|
2021
Q3 | $663K | Buy |
26,914
+10,130
| +60% | +$220K | ﹤0.01% | 8655 |
|
|
2021
Q2 | $415K | Sell |
16,784
-17,286
| -51% | -$402K | ﹤0.01% | 10038 |
|
|
2021
Q1 | $743K | Buy |
+34,070
| New | +$834K | ﹤0.01% | 8500 |
|
|
2020
Q4 | – | Sell |
-17,995
| Closed | -$507K | – | 11618 |
|
|
2020
Q3 | $507K | Buy |
+17,995
| New | +$520K | ﹤0.01% | 7644 |
|
Other funds holding RNAM
Susquehanna International Group's RNAM Position: Q1 2026 in Review
Susquehanna International Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 268,393 shares — an estimated $19.4M sold.
Susquehanna International Group first reported a position in RNAM in Q3 2020 and held it in 21 quarters. The position peaked at $19.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Susquehanna International Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 268,393 Avidity Biosciences shares in Q1 2026, an estimated $19.4M.
- Susquehanna International Group first reported a position in Avidity Biosciences in Q3 2020 and held it in 21 quarters.
- Susquehanna International Group's Avidity Biosciences position peaked at $19.4M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.